B
BriaCell Therapeutics Corp. (BCTX)
NCM – Real vaqt narxi. Valyuta: USD
3.06
+0.09 (3.03%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
3.10
+0.04 (1.31%)
Bozordan keyin: Jun 26, 2026, 7:59 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
3.06
+0.09 (3.03%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
3.10
+0.04 (1.31%)
Bozordan keyin: Jun 26, 2026, 7:59 PM EDT
Daromad taqsimoti ma'lumotlari hali hisoblanmagan.
No Data
Ushbu aksiya uchun yangiliklar yo'q.
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 7.07 | 6.05 | 10 | |
| Tezkor likvidlik nisbati | 7.07 | 5.63 | 10 | |
| Qarz/Kapital nisbati | 0.00 | 0.30 | 10 | |
| Qarz/Aktivlar nisbati | 0.00 | 1.04 | 10 | |
| Foiz to‘lov qoplami | -257.19 | -16.91 | 1.0 | |
| O‘rtacha ball | 8.2 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | N/A | N/A | N/A | N/A | N/A |
| Yalpi foyda | -15K | -16K | -83K | -107K | -113K |
| Operatsion daromad | -15M | -24M | -33M | -27M | -32M |
| Sof foyda | -27M | -21M | -5M | -26M | -31M |
| EBITDA | -15M | -24M | -33M | -27M | -32M |
| NOMI | KOEFF. | SANOAT | 5 YIL | BALL |
|---|---|---|---|---|
| Yalpi marja % | N/A | -11.73 | 1.0 | |
| Operatsion marja % | N/A | -24.60 | 1.0 | |
| Sof marja % | N/A | -172.20 | 1.0 | |
| EBITDA marja % | N/A | -201.27 | 1.0 | |
| Pul oqimi marja % | N/A | -156.39 | 1.0 | |
| O‘rtacha ball | 1.0 | |||
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | N/A | N/A | 1.0 |
| Keyingi chorak | N/A | N/A | 1.0 |
| Joriy yil | N/A | N/A | 1.0 |
| Keyingi yil | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 999 | 1.74 | N/A | 11.14 | 5.3 |
| Yil/Yil | 999 | -14.44 | N/A | 2.09 | 3.8 |
| 3 yil o‘rtacha | 999 | -120.68 | N/A | -37.48 | 3.3 |
| 5 yil o‘rtacha | 999 | -146.57 | N/A | -150.1 | 3.3 |
| O‘rtacha ball | 3.9 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |
Naqd pul zahiralari $6.9M kelgusi qarz to'lovlarini $0.0 zo'rg'a qoplaydi
Jami joriy aktivlar $25.4M jami joriy majburiyatlardan $3.6M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (0.0) tarmoq o'rtachasiga yaqin bo'lib, muvozanatli leverajni aks ettiradi
Foiz qoplash koeffitsiyenti (-257.2x) xavfli darajada past bo'lib, qarzni qaytarish xavflarini ko'rsatadi
Salbiy erkin pul oqimi -$7.2M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi